Please use this identifier to cite or link to this item:
http://hdl.handle.net/10553/47716
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Clavo, Bernardino | en_US |
dc.contributor.author | Santana Rodríguez, Norberto | en_US |
dc.contributor.author | Llontop, Pedro | en_US |
dc.contributor.author | Gutierrez, Dominga | en_US |
dc.contributor.author | Ceballos Santos, Daniel Sebastián | en_US |
dc.contributor.author | Méndez, Charlin | en_US |
dc.contributor.author | Rovira, Gloria | en_US |
dc.contributor.author | Suarez, Gerardo | en_US |
dc.contributor.author | Rey-Baltar, Dolores | en_US |
dc.contributor.author | Garcia-Cabrera, Laura | en_US |
dc.contributor.author | Martínez-Sánchez, Gregorio | en_US |
dc.contributor.author | Fiuza, Dolores | en_US |
dc.date.accessioned | 2018-11-23T15:49:35Z | - |
dc.date.available | 2018-11-23T15:49:35Z | - |
dc.date.issued | 2015 | en_US |
dc.identifier.issn | 1741-427X | en_US |
dc.identifier.uri | http://hdl.handle.net/10553/47716 | - |
dc.description.abstract | Introduction. Persistent radiation-induced proctitis and rectal bleeding are debilitating complications with limited therapeutic options. We present our experience with ozone therapy in the management of such refractory rectal bleeding. Methods. Patients () previously irradiated for prostate cancer with persistent or severe rectal bleeding without response to conventional treatment were enrolled to receive ozone therapy via rectal insufflations and/or topical application of ozonized-oil. Ten (83%) patients had Grade 3 or Grade 4 toxicity. Median follow-up after ozone therapy was 104 months (range: 52–119). Results. Following ozone therapy, the median grade of toxicity improved from 3 to 1 () and the number of endoscopy treatments from 37 to 4 (). Hemoglobin levels changed from 11.1 (7–14) g/dL to 13 (10–15) g/dL, before and after ozone therapy, respectively (). Ozone therapy was well tolerated and no adverse effects were noted, except soft and temporary flatulence for some hours after each session. Conclusions. Ozone therapy was effective in radiation-induced rectal bleeding in prostate cancer patients without serious adverse events. It proved useful in the management of rectal bleeding and merits further evaluation. | en_US |
dc.language | eng | en_US |
dc.relation.ispartof | Evidence-Based Complementary and Alternative Medicine | en_US |
dc.source | Evidence-based Complementary and Alternative Medicine[ISSN 1741-427X],v. 2015 (480369) | en_US |
dc.subject | 32 Ciencias médicas | en_US |
dc.subject | 320101 Oncología | en_US |
dc.subject.other | Ozone therapy | en_US |
dc.subject.other | Prostate cancer | en_US |
dc.title | Ozone therapy in the management of persistent radiation-induced rectal bleeding in prostate cancer patients | en_US |
dc.type | info:eu-repo/semantics/article | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.1155/2015/480369 | en_US |
dc.identifier.scopus | 2-s2.0-84940755024 | - |
dc.contributor.authorscopusid | 57190093030 | - |
dc.contributor.authorscopusid | 56072780900 | - |
dc.contributor.authorscopusid | 37041705700 | - |
dc.contributor.authorscopusid | 8616778800 | - |
dc.contributor.authorscopusid | 15834224200 | - |
dc.contributor.authorscopusid | 56816472500 | - |
dc.contributor.authorscopusid | 6506763433 | - |
dc.contributor.authorscopusid | 7101855600 | - |
dc.contributor.authorscopusid | 6505717937 | - |
dc.contributor.authorscopusid | 56386004800 | - |
dc.contributor.authorscopusid | 6603422480 | - |
dc.contributor.authorscopusid | 6506332517 | - |
dc.identifier.issue | 480369 | - |
dc.relation.volume | 2015 | en_US |
dc.investigacion | Ciencias de la Salud | en_US |
dc.type2 | Artículo | en_US |
dc.description.numberofpages | 7 | en_US |
dc.utils.revision | Sí | en_US |
dc.date.coverdate | Agosto 2015 | en_US |
dc.identifier.ulpgc | Sí | en_US |
dc.contributor.buulpgc | BU-MED | en_US |
dc.description.sjr | 0,77 | - |
dc.description.jcr | 1,931 | - |
dc.description.sjrq | Q1 | - |
dc.description.jcrq | Q2 | - |
dc.description.scie | SCIE | - |
item.grantfulltext | none | - |
item.fulltext | Sin texto completo | - |
crisitem.author.dept | GIR IUIBS: Farmacología Molecular y Traslacional | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.dept | GIR IUIBS: Farmacología Molecular y Traslacional | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.dept | Departamento de Ciencias Médicas y Quirúrgicas | - |
crisitem.author.orcid | 0000-0003-2522-1064 | - |
crisitem.author.orcid | 0000-0003-2384-4524 | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.fullName | Clavo Varas,Bernardino | - |
crisitem.author.fullName | Santana Rodríguez,Norberto | - |
crisitem.author.fullName | Ceballos Santos, Daniel Sebastián | - |
Appears in Collections: | Artículos |
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.